MicroRNAs move into cancer research
Article Abstract:
The gene-silencing technique known as RNA interference is used by many cancer researchers to effectively mute the expression of genes that drive malignancies. Scientists have known for many years that microRNAs, which are 21- to -25- nucleotide-long regulatory molecules, influence normal growth and development in plants and animals.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Funding, advances invigorate TB fight
Article Abstract:
The emergence of multidrug-resistant TB strains of Mycobacterium tuberculosis and coinfection with HIV are the major complications in treating the patients. The complete genome sequence of the best characterized strain of M tuberculosis would help advance efforts to develop better diagnostic tests, drugs and vaccines.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Trials assess Myasthenia gravis therapies
Article Abstract:
The article discusses on Myasthenia Gravis, a chronic autoimmune neuromuscular disorder and the efforts to develop and test potential therapies.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: US ponders unlocking the gates to prisoner research. Criticism swells against AIDS program's abstinence policy
- Abstracts: Ramping up rehabilitation research urged as a "public health imperative". Stress, sleep loss, and substance abuse create potent recipe for college depression
- Abstracts: Abortion and the risk of breast cancer: is there a believable association? Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk